Total Payments
$34,847
2024 Payments
$1,190
Companies
46
Transactions
456
Medicare Patients
7,342
Medicare Billing
$604,168
Payment Breakdown by Category
Other$23,015 (66.0%)
Food & Beverage$8,672 (24.9%)
Travel$2,796 (8.0%)
Education$364.10 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,015 | 8 | 66.0% |
| Food and Beverage | $8,672 | 432 | 24.9% |
| Travel and Lodging | $2,796 | 7 | 8.0% |
| Education | $364.10 | 9 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $25,968 | 37 | $0 (2022) |
| HEARTFLOW, INC. | $1,408 | 10 | $0 (2024) |
| Amgen Inc. | $1,186 | 81 | $0 (2024) |
| PFIZER INC. | $970.79 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $734.23 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $650.44 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $533.68 | 44 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $517.22 | 26 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $419.80 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $340.79 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,190 | 66 | PFIZER INC. ($187.49) |
| 2023 | $2,146 | 51 | HeartFlow, Inc. ($1,364) |
| 2022 | $891.40 | 54 | E.R. Squibb & Sons, L.L.C. ($193.10) |
| 2021 | $378.17 | 23 | Amgen Inc. ($102.43) |
| 2020 | $3,250 | 34 | Astellas Pharma US Inc ($2,750) |
| 2019 | $11,814 | 101 | Astellas Pharma US Inc ($10,152) |
| 2018 | $7,989 | 75 | Astellas Pharma US Inc ($6,831) |
| 2017 | $7,188 | 52 | Astellas Pharma US Inc ($6,158) |
All Payment Transactions
456 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Genetic Disease | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: DIABETES | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $122.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.49 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Genetic Disease | ||||||
| 09/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Coronary | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Not Applicable | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,072 | 2,612 | $375,522 | $162,691 |
| 2022 | 29 | 1,863 | 2,394 | $347,640 | $158,019 |
| 2021 | 29 | 1,930 | 2,417 | $367,920 | $160,700 |
| 2020 | 30 | 1,477 | 1,852 | $279,360 | $122,758 |
Total Patients
7,342
Total Services
9,275
Medicare Billing
$604,168
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 497 | $72,065 | $43,226 | 60.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 175 | 178 | $71,200 | $24,927 | 35.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 68 | 68 | $49,300 | $21,329 | 43.3% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 68 | 136 | $16,320 | $10,951 | 67.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 56 | 224 | $22,400 | $9,535 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 147 | $15,435 | $8,823 | 57.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 52 | 52 | $16,900 | $7,104 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $13,160 | $6,317 | 48.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 119 | 121 | $15,400 | $5,719 | 37.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 87 | 88 | $14,520 | $3,965 | 27.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 320 | 355 | $14,200 | $3,582 | 25.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 13 | 13 | $5,850 | $2,325 | 39.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 32 | 32 | $4,800 | $1,803 | 37.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 23 | 32 | $4,000 | $1,464 | 36.6% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 18 | 36 | $5,040 | $1,192 | 23.7% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 14 | 16 | $2,320 | $1,086 | 46.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 155 | 162 | $4,859 | $990.86 | 20.4% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 15 | 16 | $2,880 | $982.93 | 34.1% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 22 | 29 | $1,885 | $962.53 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,683 | $908.58 | 54.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 19 | 33 | $4,125 | $878.23 | 21.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 15 | 26 | $1,820 | $576.00 | 31.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 21 | 33 | $1,980 | $545.92 | 27.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 34 | 34 | $1,700 | $540.54 | 31.8% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 17 | 18 | $990.00 | $486.59 | 49.2% |
About Dr. Brian Riegel, MD
Dr. Brian Riegel, MD is a Cardiovascular Disease healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992788657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Riegel, MD has received a total of $34,847 in payments from pharmaceutical and medical device companies, with $1,190 received in 2024. These payments were reported across 456 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,015).
As a Medicare-enrolled provider, Riegel has provided services to 7,342 Medicare beneficiaries, totaling 9,275 services with total Medicare billing of $604,168. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology
- Location Williamsville, NY
- Active Since 11/26/2005
- Last Updated 11/08/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992788657
Products in Payments
- LEXISCAN (Drug) $12,327
- Lexiscan (Drug) $3,296
- FFRct (Device) $1,408
- ELIQUIS (Drug) $1,222
- Repatha (Biological) $934.98
- PRADAXA (Drug) $378.94
- JARDIANCE (Drug) $352.22
- XARELTO (Drug) $340.79
- PRALUENT (Drug) $328.82
- ENTRESTO (Drug) $302.89
- VYNDAQEL (Drug) $273.21
- Corlanor (Drug) $250.57
- LEQVIO (Drug) $230.79
- MULTAQ (Drug) $188.40
- BRILINTA (Drug) $173.72
- Cologuard Collection Kit (Device) $169.24
- Barostim Neo System (Device) $157.12
- CAMZYOS (Drug) $150.20
- LOKELMA (Drug) $137.84
- HeartMate 3 Left Ventricular Dev (Device) $130.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Williamsville
Dr. Chee Kim, Md, MD
Cardiovascular Disease — Payments: $264,173
Cardiovascular Disease $264,173
Dr. Jai Wadhwani, M.d, M.D
Cardiovascular Disease — Payments: $254,917
Cardiovascular Disease $254,917
Dr. Donald Switzer, Md, MD
Cardiovascular Disease — Payments: $43,807
Cardiovascular Disease $43,807
Dr. Ranjan Bhayana, Md, MD
Cardiovascular Disease — Payments: $37,934
Cardiovascular Disease $37,934
Richard Corbelli, Md, MD
Cardiovascular Disease — Payments: $24,647
Cardiovascular Disease $24,647
Dr. Judy Joy-Pardi, M.d, M.D
Cardiovascular Disease — Payments: $10,856
Cardiovascular Disease $10,856